313 related articles for article (PubMed ID: 19036442)
41. Definition, diagnosis, and management of intravascular large B-cell lymphoma: proposals and perspectives from an international consensus meeting.
Ponzoni M; Ferreri AJ; Campo E; Facchetti F; Mazzucchelli L; Yoshino T; Murase T; Pileri SA; Doglioni C; Zucca E; Cavalli F; Nakamura S
J Clin Oncol; 2007 Jul; 25(21):3168-73. PubMed ID: 17577023
[TBL] [Abstract][Full Text] [Related]
42. Primary endobronchial non-Hodgkin lymphoma in an 80-year-old patient with prostate cancer.
Hardavella G; Thalassinos N; Anastasiou N
Interact Cardiovasc Thorac Surg; 2009 Oct; 9(4):739-40. PubMed ID: 19589791
[TBL] [Abstract][Full Text] [Related]
43. A clinicopathological study of 13 cases of intravascular lymphoma: experience in a single institution over a 9-yr period.
Matsue K; Asada N; Takeuchi M; Yamakura M; Kimura S; Odawara J; Aoki T
Eur J Haematol; 2008 Mar; 80(3):236-44. PubMed ID: 18081700
[TBL] [Abstract][Full Text] [Related]
44. Kidney-limited intravascular large B cell lymphoma: a distinct variant of IVLBCL?
Kameoka Y; Takahashi N; Komatsuda A; Tagawa H; Hamai K; Hirokawa M; Wakui H; Ichinohasama R; Sawada KI
Int J Hematol; 2009 May; 89(4):533-537. PubMed ID: 19322627
[TBL] [Abstract][Full Text] [Related]
45. Rituximab-induced severe acute thrombocytopenia: a case report and review of literature.
Dhand S; Bahrain H
Cancer Invest; 2008 Nov; 26(9):913-5. PubMed ID: 19034773
[TBL] [Abstract][Full Text] [Related]
46. Regression of cutaneous intravascular lymphoma with rituximab.
Han K; Haley JC; Carlson K; Pinter-Brown L; Soriano T
Cutis; 2003 Aug; 72(2):137-40. PubMed ID: 12953938
[TBL] [Abstract][Full Text] [Related]
47. [Low-grade cutaneous B-cell lymphoma: Failure of intralesional rituximab (Mabthera)].
Abasq C; Duval-Modeste AB; Courville P; Joly P
Ann Dermatol Venereol; 2008; 135(6-7):509-11. PubMed ID: 18598807
[No Abstract] [Full Text] [Related]
48. B cell reconstitution after rituximab treatment of lymphoma recapitulates B cell ontogeny.
Anolik JH; Friedberg JW; Zheng B; Barnard J; Owen T; Cushing E; Kelly J; Milner EC; Fisher RI; Sanz I
Clin Immunol; 2007 Feb; 122(2):139-45. PubMed ID: 17008130
[TBL] [Abstract][Full Text] [Related]
49. Acute renal failure due to a primary renal B-cell lymphoma.
Lopez R
Am J Kidney Dis; 2008 Oct; 52(4):808; author reply 808-9. PubMed ID: 18805357
[No Abstract] [Full Text] [Related]
50. Comparative clinicopathological study of primary CNS diffuse large B-cell lymphoma and intravascular large B-cell lymphoma.
Imai H; Shimada K; Shimada S; Abe M; Okamoto M; Kitamura K; Kinoshita T; Shiraishi T; Nakamura S
Pathol Int; 2009 Jul; 59(7):431-7. PubMed ID: 19563405
[TBL] [Abstract][Full Text] [Related]
51. Nephrotic syndrome in a patient with intravascular lymphomatosis.
Kakumitsu H; Higuchi M; Tanaka K; Shibuya T
Intern Med; 2003 Jan; 42(1):98-101. PubMed ID: 12583628
[TBL] [Abstract][Full Text] [Related]
52. [Acute renal failure due to malignant lymphoma infiltration].
Zbiti N; Alhamany Z; Houssaini TS; Rhou H; Benamar L; Ezaitouni F; Bayahia R; Ouzeddoun N
Nephrol Ther; 2010 Dec; 6(7):602-5. PubMed ID: 20920898
[TBL] [Abstract][Full Text] [Related]
53. Cutaneous B-cell lymphoma treated with rituximab infusions.
Schneider LA
Acta Derm Venereol; 2006; 86(6):550-1. PubMed ID: 17106608
[No Abstract] [Full Text] [Related]
54. Re: Rituximab monotherapy is highly effective in splenic marginal zone lymphoma.
Bennett M; Yegena S; Dave HP; Schechter GP
Hematol Oncol; 2008 Jun; 26(2):114. PubMed ID: 18271062
[No Abstract] [Full Text] [Related]
55. Clinical applications of rituximab in allogeneic stem cell transplantation: anti-tumor and immunomodulatory effects.
Ratanatharathorn V; Pavletic S; Uberti JP
Cancer Treat Rev; 2009 Dec; 35(8):653-61. PubMed ID: 19682801
[TBL] [Abstract][Full Text] [Related]
56. An imaging-based rapid evaluation method for complement-dependent cytotoxicity discriminated clinical response to rituximab-containing chemotherapy.
Mishima Y; Sugimura N; Matsumoto-Mishima Y; Terui Y; Takeuchi K; Asai S; Ennishi D; Asai H; Yokoyama M; Kojima K; Hatake K
Clin Cancer Res; 2009 May; 15(10):3624-32. PubMed ID: 19417028
[TBL] [Abstract][Full Text] [Related]
57. Immunochemotherapy for Bcl-2 and MUM-negative aggressive primary cutaneous B-cell non-Hodgkin's lymphoma.
Colovic N; Jurisic V; Terzic T; Atkinson HD; Colovic M
Arch Dermatol Res; 2009 Oct; 301(9):689-92. PubMed ID: 19495780
[TBL] [Abstract][Full Text] [Related]
58. Primary intravascular large B cell lymphoma of the endometrium.
Xia Y; Wang Y; Jiang Y; Yu W; Li Y; Xiang F; Wang C
Acta Histochem; 2014 Jun; 116(5):993-6. PubMed ID: 24418320
[TBL] [Abstract][Full Text] [Related]
59. [Intravascular malignant lymphomatosis].
Koto A
Rinsho Shinkeigaku; 1995 Dec; 35(12):1464-6. PubMed ID: 8752431
[TBL] [Abstract][Full Text] [Related]
60. Improvement of peripheral nervous system manifestations of B-cell non-Hodgkin's lymphoma after rituximab therapy.
Briani C; Zambello R; Cavallaro T; Ferrari S; Lucchetta M; Pollanz S; Grisold W
J Peripher Nerv Syst; 2009 Jun; 14(2):146-8. PubMed ID: 19691537
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
